|
|
| March 17, 2017: Dr. E. Magnus Ohman and Dr. Serge Korjian Discuss: GEMINI-ACS-1: A Randomized Trial Evaluating Clinically Significant Bl |
Dr. E. Magnus Ohman and Dr. Serge Korjian Discuss: GEMINI-ACS-1: A Randomized Trial
Evaluating Clinically Significant Bleeding With Low-Dose Rivaroxaban Versus Aspirin, in
Addition to P2Y12 Inhibition, for Patients After Acute Coronary Syndromes
TBD
[ Download video ] |
|
No comments have been submitted
|